超频三(300647) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥140,557,311.13, a decrease of 50.06% compared to ¥180,496,782.73 in the same period last year[2] - The net profit attributable to shareholders was a loss of ¥28,874,149.22, representing a 4.10% increase in loss compared to a loss of ¥27,679,372.36 in the previous year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥31,293,603.15, which is a 9.83% increase in loss compared to a loss of ¥28,853,630.68 in the same period last year[2] - The net cash flow from operating activities was negative at ¥81,686,894.26, a significant decline of 153.20% compared to the previous year[2] - The company reported a net loss attributable to shareholders of ¥288,588,044.57, worsening from a loss of ¥241,767,374.69 in the previous period[15] - The net profit for Q3 2024 was -83,448,918.13 CNY, an improvement from -106,595,354.87 CNY in the same period last year, representing a reduction in losses of approximately 21.7%[17] - Operating profit for Q3 2024 was -104,336,421.24 CNY, compared to -133,310,276.43 CNY in Q3 2023, indicating a 21.7% decrease in operating losses[17] - The total profit for Q3 2024 was -104,192,259.98 CNY, an improvement from -133,379,684.86 CNY in Q3 2023, indicating a reduction in total losses of about 21.8%[17] Assets and Liabilities - The total assets as of September 30, 2024, were ¥2,197,137,018.40, a decrease of 7.36% from ¥2,238,706,986.38 at the end of the previous year[3] - The equity attributable to shareholders was ¥939,907,961.54, down 5.88% from ¥989,027,616.57 at the end of the previous year[3] - Total current assets decreased to ¥900,789,747.99 from ¥1,130,769,580.48, reflecting a decline of 20.3%[14] - Total liabilities decreased to ¥1,287,000,463.11 from ¥1,380,650,971.41, a reduction of 6.8%[15] - The company’s total assets decreased to ¥2,197,137,018.40 from ¥2,371,771,803.65, a decline of 7.3%[14] Cash Flow - Cash and cash equivalents decreased by 74.74% to ¥78,098,888.41 from ¥309,153,632.55 at the beginning of the year, primarily due to reduced collections and increased payments[6] - Cash and cash equivalents at the end of Q3 2024 were ¥78,098,888.41, a significant decrease of 74.7% from ¥309,153,632.55 at the beginning of the period[13] - The net cash flow from operating activities was -81,686,894.26 CNY, compared to -32,261,850.04 CNY in the previous year[20] - The total cash and cash equivalents at the end of the period were 70,324,411.80 CNY, down from 401,184,870.90 CNY year-over-year[20] - The net cash flow from investment activities was -77,207,852.22 CNY, compared to -236,554,726.20 CNY in the same quarter last year[20] - The company’s cash flow from operating activities decreased significantly, indicating potential challenges in operational efficiency[20] Operational Metrics - Operating costs decreased by 34.12% to ¥453,431,662.92, attributed to a decline in sales prices and costs[7] - Total operating revenue for Q3 2024 was ¥540,974,183.14, a decrease of 22.9% compared to ¥701,315,319.00 in the same period last year[16] - Total operating costs for Q3 2024 were ¥602,097,570.25, down 29.3% from ¥852,434,717.66 year-over-year[16] - The company experienced a decrease in sales revenue from 751,690,576.88 CNY in Q3 2023 to 518,402,910.05 CNY in Q3 2024, a decline of approximately 30.9%[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 41,271[8] - The largest shareholder, Liu Yu, holds 15.46% of the shares, amounting to 70,697,682 shares, with 14,950,000 shares pledged[9] Research and Development - Development expenses surged by 271.11% to ¥15,516,785.60, mainly due to new expenditures on subsidiary R&D projects[7] - Research and development expenses for Q3 2024 were ¥32,165,499.59, a decrease of 8.6% compared to ¥35,180,678.15 in the same period last year[16] Non-Recurring Items - The company reported non-recurring gains of ¥2,419,453.93 for the current period, with government subsidies contributing ¥4,468,847.00[4] - The company has not reclassified any non-recurring gains and losses as regular gains and losses[5] - The company reported a 100% loss in fair value changes due to hedging activities during the reporting period[7]